ArticleScientific reports2026
Enhancement of essential oil yield and quality of basil (Ocimum basilicum L.) via intercropping system, AMF and PGPR.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basil (Ocimum basilicum L.) and fenugreek (Trigonella foenum-graecum L.) are essential oil-bearing medicinal plants that could be used for food spice, antimicrobial and antioxidant properties. Plant growth-promoting rhizobacteria (PGPR) and arbuscular mycorrhizal fungi (AMF) promote crop growth and yield through different mechanisms. A two-year study was conducted to investigate the effects of fertilizer treatments on growth characteristics, essential oil (EO) yield and compositions of basil in intercropping with fenugreek. A factorial experiment was arranged in a randomized complete block design with three replicates in 2021 and 2022 in West Azarbaijan, Iran. The first factor was cropping pattern including sole cropping of basil and fenugreek, strip intercropping of basil (B)-fenugreek (F) with replacement method in the ratios of 2B:2 F, 4B:2 F, 5B:3 F and an additive intercropping of 100% basil + 50% fenugreek (100B:50 F). The second factor was fertilizer at three levels including application of local recommended dose of chemical fertilizer (RDF), 50% RDF + biofertilizer of AMF + PGPR (50% RDF + Bio) and biofertilizer of AMF + PGPR (Bio). The greatest basil height was observed in 2B:2 F cropping pattern and 50% RDF + Bio treatment (50.39 cm). The greatest yield of dry herbage was observed in 5B:3B cropping pattern with RDF and 50% RDF + Bio treatments. The highest yields of EO were observed in sole basil (0.85 g m− 2) and 5B:3 F intercropping (0.72 g m− 2), in 50% RDF + Bio treatment. Methyl chavicol, methyl eugenol, β-caryophyllene and 1,8-cineole, were the main chemical constitutes of EO. The contents of major components of EO were affected differently by cropping pattern and fertilizer. The greatest content of methyl chavicol (53.7%), was observed in 2B:2 F and Bio fertilizer treatment. Also, the highest content of methyl eugenol was obtained in 4B:2 F and 50% RDF + Bio fertilizer treatment. The results of EO compositions also were approved by principal component analysis (PCA). At all treatments, the land equivalent ratios (LERT) were more than 1.0 that indicates the advantage of intercropping patterns compared with sole crops. The highest LERT (1.99) was obtained in 2B:2 F intercropping with 50% RDF + Bio treatment. We can conclude that application of 50% RDF + Bio fertilizer treatment in 2B:2 F intercropping, increased the productivity of basil-fenugreek intercropping, improved the EO compositions and could be recommended to the growers in sustainable production of basil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.